Nur zu Informationszwecken. Lassen Sie sich immer von medizinischem Fachpersonal beraten.
MPMediPriceHubArzneimittelpreise im Überblick
PRODUCT INFORMATION

Scenesse 16mg Implant(Afamelanotide)

afamelanotide

Scenesse 16mg Implant(Afamelanotide)
Reference priceEUR €4.84Original source price: INR 440.00. Converted estimates are available by currency selection.
BrandScenesse
ManufacturerClinuvel Pharmaceuticals
Prescription requiredYes

Description

Scenesse 16mg Implant(Afamelanotide) is a medicine catalog record in the MediPriceHub database. Active ingredient: afamelanotide. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: Clinuvel Pharmaceuticals. Therapeutic category: Medicine Library > Dermatology Medicines > Vitiligo medicine. Pack information: 16. Origin country or market: United States. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.

Benefits

SCENESSE ® is indicated to increase pain free light exposure in adult patients with a history of phototoxic reactions from erythropoietic protoporphyria (EPP). SCENESSE is a melanocortin 1 receptor (MC1-R) agonist indicated to increase pain free light exposure in adult patients with a history of phototoxic reactions from erythropoietic protoporphyria (EPP)

How to Use

Use afamelanotide under the supervision of a qualified healthcare professional. Use it only according to the approved label and the instructions of a qualified healthcare professional. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.

Specification

Active ingredient: afamelanotide. Pack size: 16. Pack unit: unit. Manufacturer: Clinuvel Pharmaceuticals. Origin country: United States. Source category: Medicine Library > Dermatology Medicines > Vitiligo medicine. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.

Side Effects

Possible adverse effects vary by active ingredient, dose, route, treatment duration, and patient condition. Common issues may include gastrointestinal symptoms, headache, dizziness, fatigue, rash, allergic reactions, or abnormal laboratory tests. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, confusion, serious bleeding, signs of infection, or rapidly worsening symptoms. The approved local prescribing information is the controlling source for the complete adverse-reaction profile.

Diese Angaben dienen nur als Referenz. Lassen Sie sich vor der Anwendung eines Medikaments von medizinischem Fachpersonal beraten.